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Case Reports
A 55-Year-Old Man With Rapid Onset Rectosigmoid Mass 
and Hepatic Metastases with an AFP of > 3 Million ng/mL
Francis Kim, MD
Case
A 55-year-old male with a past medical history of ulcerative 
colitis diagnosed in 1999, Barrett’s esophagus, hyperlipidemia, 
and diabetes mellitus presented with a 2-week duration of 
daily constant abdominal pain. He described the pain as a 
sharp, epigastric pain not worsened with food intake or bowel 
movements. He was unable to tolerate any oral intake for a week 
prior to admission secondary to increased epigastric pain. He 
stated an increase in bowel movements to 1 per day that was 
softer and less formed than usual. He also stated he had a near 
syncopal episode on the day of admission and reported dizziness. 
The patient denied any bright red blood per rectum or having 
dark stools. He states he also had some fevers, chills, and a sore 
throat for 3 days duration. He had tried some Pepto Bismol 
without any improvement.
Medications he was taking included 6-mercaptopurine 50mg 
daily, pantoprazole 40mg twice a day, levemir 10 Units nightly, 
and cholestyramine 4g daily. He denied any alcohol, smoking, or 
drug use. He worked as a storeowner without any recent travel 
history. On admission, his vitals were: temperature 101 degrees 
Fahrenheit, pulse rate 54 beats per minute, respiratory rate 20 per 
minute, oxygen saturation 99% on room air, and blood pressure 
of 111/65 mmHg. On physical exam, the only significant finding 
was right upper quadrant tenderness to palpation on abdominal 
exam. The rest of the exam was normal. He was noted to have a 
positive hemoccult.
Lab work showed a white blood count of 10.5 B/L, Hemoglobin 
of 9 g/dL, and Platelets of 398 B/L. The chemistry 7 panel was 
within normal limits and his liver function tests showed slightly 
increased total bilirubin at 1.5 mg/dL and direct bilirubin at 
0.6 mg/dL with an otherwise normal panel. The patient had 
imaging performed 2 months prior to admission performed 
for recent weight loss. The MRI abdomen 2 months prior to 
admission showed: “mild hepatic steatosis, multiple sub 5 mm T2 
hyperintense foci throughout the liver which are most likely cysts. 
There is a 1.0 x 0.8 cm cyst in the right hepatic lobe. No evidence 
of malignancy in the abdomen. Specifically, the pancreas appears 
normal.” The patient’s most recent colonoscopy was performed 
11 months prior to admission, which showed “few inflammatory 
appearing polyps in the rectum… There was mild colitis involving 
the rectum and sigmoid and some scars.” The rest of the colon 
was stated to appear endoscopically normal. The biopsies from 
that colonoscopy did not show any malignancy.
Hospital Course
The patient was admitted with concern for an ulcerative colitis 
flare versus infectious colitis. He was started on antibiotics 
and was ordered for a CT abdomen and pelvis. This CT scan 
showed a circumferential mass involving the sigmoid colon, a 
filling defect within the left main portal vein, extensive hepatic 
masses, largest seen in the right hepatic lobe measure 6.2 x 5.1 
x 6.6 cm and retroperitoneal lymphadenopathy. At this point, 
the patient underwent ultrasound-guided biopsy of the liver 
and oncology was consulted. AFP (alpha feto-protein), CEA 
(carcino embryonic antigen), and CA (carbohydrate antigen) 
19-9 levels were sent. The CEA and CA 19-9 levels returned 
normal, but the AFP level came back elevated at 2.4 million ng/
mL. Subsequent rechecks of his AFP level peaked at 3.5 million 
NG/mL. LDH (lactate dehydrogenase) was markedly elevated 
>600 units/L. Beta-HCG (human chorionic gonadotropin) was 
negative. The fine needle aspirate of the liver showed poorly 
differentiated carcinoma. The immunohistochemical profile 
stated that the primary site of the carcinoma could not be stated 
with certainty. A sigmoidoscopy was performed and revealed 
a partially obstructing colon mass located at the rectosigmoid 
junction, mild colitis, and external hemorrhoids. Biopsy of this 
mass showed poorly differentiated adenocarcinoma. Colorectal 
surgery did not see an emergent need for resection as there 
was no acute obstruction and he was managed medically. To 
further work-up this malignancy, a testicular ultrasound was 
performed which was negative for any masses. At this point, due 
to the markedly elevated AFP and LDH, it was determined that 
this malignancy was an extragonadal germ-cell tumor. He was 
started on chemotherapy of bleomycin, etoposide, and cisplatin. 
His AFP decreased to 28,000 with chemotherapy in the ensuing 
months with stabilization of his disease on repeat imaging. 
However, the patient decompensated and passed away 7 months 
after initial diagnosis.
Discussion
In the initial differential diagnosis of this patient with a new 
finding of a rectosigmoid mass with hepatic masses, colorectal 
cancer was considered. It is the most common GI tumor and also 
takes into account the patient’s history of ulcerative colitis. The 
diagnosis of ulcerative colitis does increase the risk of colorectal 
cancer. In fact colorectal cancer accounts for around 15% of all 
inflammatory bowel disease deaths.1 However in this case, the 
rapid development of this cancer in under a year (from his last 
colonoscopy which showed no malignancy) would be unusual as 
colon adenocarcinoma is typically slower progressing. Also, the 
tumor markers that are associated with colorectal cancer, such 
as carcinoembryonic antigen (CEA), and carbohydrate antigen 
(CA) 19-9 were within normal limits.2 Hepatocellular carcinoma 
(HCC) is another tumor that has been shown to produce elevated 
AFP markers above 400ng per milliliter. The diagnosis of HCC 
is made by incorporating typical imaging (CT/MRI) features 
specific for HCC, AFP levels, and if needed, liver biopsy.3 For 
this patient, the liver biopsy did not reveal HCC. It was in the 
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evaluation of the alpha feto-protein and LDH levels that the 
diagnosis of extragonadal germ cell tumor was considered.
AFP is a marker usually produced by the fetal yolk sac that becomes 
undetectable in normal men. However, elevations in AFP can be 
seen in germ cell tumors, specifically non-seminomatous germ 
cell tumors. Usually, AFP values greater than 10,000mg/L are 
found exclusively in non-seminomatous germ cell tumors or 
hepatocellular carcinoma. Opposed to non-seminomatous germ 
cell tumors, seminomatous germ cell tumors by definition do 
not produce AFP.4
Extragonadal germ cell tumors are germ cell tumors that do not 
originate in either the testes or the ovaries. As this patient had a 
normal testicular ultrasound, it was determined that his primary 
tumor was extragonadal in location. Extranodal germ cell tumors 
are relatively uncommon, accounting for only 1-5% of all germ 
cell tumors. They tend to arise in midline locations in adults with 
the most common sites including the anterior mediastinum, 
retroperitoneum, and the brain.5 A possible explanation of the 
extragonadal location is that there is a reverse migration of the 
transformed totiportent germ cells.6
In considering the diagnosis of extragonadal germ cell tumors, it 
is mandatory to check for testicular masses via physical exam and 
ultrasound. Up to one third of patients can have TIN (testicular 
intraepithelial neoplasia) in one or both testicles that appear to be 
normal on imaging and ultrasound. However, a testicular biopsy 
is not recommended due to the fact that all extragonadal germ 
cell tumors will most likely receive the cisplatin-based therapy, 
which will eliminate the majority of TIN. The diagnosis of germ 
cell tumors (GCT) is supported by elevated AFP or B-HCG 
levels. LDH is also an important prognostic marker of disease 
but is less sensitive and specific to GCT. Placental alkaline 
phosphatase (PLAP) staining in biopsy specimens can also be 
used to diagnose GCTs. The isochrome i12p is also very specific 
for this tumor entity.7 The biopsy specimen from this case came 
back negative for both PLAP and i12p.
However, in cases in which there is unequivocal elevation of AFP 
or B-HCG levels, chemotherapy should be the first line treatment 
without delay as germ cell tumors have been known to have 
curative potential with cisplatin based chemotherapy regimens. 
Markers of poor outcome include hepatic, osseous, and/or 
brain metastasis, and high serum levels of LDH, AFP, or HCG.6 
Once the diagnosis of extragonadal germ cell tumor was made 
in this case, the patient was started on bleomycin, etoposide, 
and cisplatin therapy. In the ensuing months, repeat CT scans 
showed stabilization and some mild improvement in the size of 
his cancer. Repeat AFP levels also dropped precipitously from 
3.5 million to 28,000 ng/mL. Despite some positive signs, he also 
had many poor prognostic indicators including his metastatic 
disease, high AFP levels, and high LDH levels.
In conclusion germ cell tumors, and more specifically 
non-seminomatous GCTs, should be considered in patients 
with greatly elevated AFP levels. In a male patient, a testicular 
ultrasound should be performed to rule out primary testicular 
cancer. Once a germ cell tumor has been diagnosed, due to the 
historically good response to chemotherapy the patient should 
be started on a cisplatin-based chemotherapy. 
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